Alternatives · ranked by WeighScore
Alternatives to Form Health
Form Health grades C (60.6/100), #354 of 544 on our scorecard. Here are the other providers we've graded on the same six dimensions — ranked by WeighScore, highest first.
You're comparing against
Form Health →Our top-graded alternative
CoreAge Rx leads the full scorecard.
Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
More alternatives, ranked
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
Ark Health is a national direct-to-consumer telehealth platform with one of the widest menus in the directory — compounded semaglutide ($169/mo), tirzepatide ($249/mo) and oral semaglutide ($125/mo), plus brand Ozempic and Mounjaro and wellness adjuncts like Sermorelin and MIC/B12.
Levity is a telehealth weight loss provider dispensing FDA-approved branded GLP-1 medications only, with no compounded options.
FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.
A compounded tirzepatide and semaglutide program for women that reaches all 50 states and keeps a brand-name Ozempic path open — but its $179 and $149 headline rates are yearly-subscription prices, not monthly ones.
Amazon One Medical is the unified Amazon GLP-1 channel — One Medical clinicians prescribe FDA-approved Wegovy, Zepbound, and Foundayo (no compounded products), and Amazon Pharmacy fulfills with same-day delivery across roughly 3,000 US cities plus pickup kiosks at select One Medical locations.
The 6 above are the closest matches to Form Health on the WeighScore. Every provider we grade — all 544 of them — is scored on the same six factors: browse every graded provider.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.